Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

  • Time News Reports on Solomon Study of Risks of Misuse of McDonald Criteria for Diagnosing MS
    May 12, 2023 by Lucy Gardner Carson
    (MAY 12, 2023) A group of researchers led by Andrew Solomon, M.D., associate professor of neurological sciences, tested different groups of neurologists using the McDonald criteria for diagnosing multiple sclerosis (MS) and showed that knowledge gaps or misunderstandings often led to errors, Time News reported. Various studies show that the criteria are sometimes incorrectly applied by neurological specialists, including MS specialists.
    Read full story at Time News
  • Invention to Venture: Larner Creators Bring Medical Innovations to Marketplace
    May 11, 2023 by John Turner
    The Larner College of Medicine has been at the vanguard of technology transfer over the past decade, supporting patents and commercialization of faculty research, which has led to several successful startups. Recent examples of commercially successful innovations by Larner faculty include Prolocor, a startup company focused on developing a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Medscape Interview: Dana Allison ’24 Presents at American Academy of Neurology Meeting
    May 10, 2023 by Lucy Gardner Carson
    (MAY 10, 2023) Larner Class of 2024 medical student Dana Allison was interviewed by Medscape about presenting her research on Virtual Reality Interventions for Autistic Spectrum Disorder Therapy at the 2023 American Academy of Neurology Meeting in Boston.
    Read full story at Medscape
  • Sprague Is Optimistic about New Breast Cancer Screening Guidelines, says WCAX-TV
    May 10, 2023 by Lucy Gardner Carson
    (MAY 10, 2023) A federal health task force now recommends that all women with an average risk of breast cancer start screening every other year beginning at age 40 — rather than at age 50, as was recommended in the previous update in 2016, WCAX-TV reported. Brian Sprague, Ph.D., professor of surgery and biochemistry, hopes this will reverse the decline in screening that UVM Cancer Center research has shown for the past several years. “I’m hoping this will help,” he says.
  • Withers’ Support of Controversial but Promising Treatment for Depression Reported by Seven Days
    May 10, 2023 by Lucy Gardner Carson
    (MAY 10, 2023) Natasha Withers, D.O., clinical assistant professor of family medicine, will soon start treating depression with a mind-altering drug that’s shown promise in helping people who don’t respond to traditional medicine — despite lingering questions about the drug’s long-term safety and effectiveness — Seven Days reported.
    Read full story at Seven Days

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Check out our newsletter archive:

December 2021

March 2022

August 2022

SpecialEditionAug2022

June 2023

Fall 2023

Winter 2024

Spring 2024

Summer 2024

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!